Toxicity risk assessment for chemical-induced human health hazards relies mainly on data obtained from animal experimentation, human studies and epidemiology. In vitro testing for acute toxicity based on cytotoxicity assays predicts 70 -80 % of rodent and human toxicity. The nervous system is particularly vulnerable to chemical exposure which may result in different toxicity features. Acute human toxicity related to adverse neuronal function is usually a result of over-excitation or depression of the nervous system. The major molecular and cellular mechanisms involved in such reactions include GABAergic, glutamatergic and cholinergic neurotransmission, regulation of cell and mitochondrial membrane potential, and those critical for maintaining central nervous system functionality, such as controlling cell energy. In this work, a set of chemicals that are used in pharmacy, industry, biocide treatments or are often abused by drug users are tested for their effects on GABAA receptor activity, GABA and glutamate transport, cell membrane potential and cell viability in primary neuronal cultures. GABAA receptor function was inhibited by compounds for which seizures have been observed after severe human poisoning. Commonly abused drugs inhibit GABA uptake but not glutamate uptake. Most neurotoxins altered membrane potential. The GABAA receptor, GABA uptake and cell membrane potential assays were those that identified the highest number of chemicals as toxic at low concentrations. These results show that in vitro cell assays may identify compounds that produce acute neurotoxicity in humans, provided that in vitro models expressing neuronal targets relevant for acute neural dysfunctions are used.
Introduction
Toxicity risk assessment for chemical-induced human health hazards relies mainly on data obtained from animal experimentation, human studies and epidemiology. The nervous system is particularly vulnerable to chemical exposure; its complexity results in multiple potential target sites with different toxicity features. Acute human toxicity related to adverse neuronal function is mainly a result of over-excitation or depression of the peripheral or central nervous system (CNS). The major molecular and cellular mechanisms involved in such effects include GABAergic, glutamatergic and cholinergic neurotransmission, regulation of cell and mitochondrial membrane potential, and those critical for maintaining CNS functionality, such as controlling cell energy. Severe disturbance of these mechanisms may result in convulsions, fatal central depression and cell death. Compared to other tissues, nerve cells have little ability to replace themselves or regenerate, which limits full recovery when cell damage occurs. Therefore, it is crucial to develop models that predict and can detect neurotoxic chemicals. Recently In vitro testing for acute toxicity based on general cytotoxicity assays, such as the Registry of Cytotoxicity (RC) and the Multicentre Evaluation of In Vitro Cytotoxicity (MEIC), can predict 70 -80 % of rodent and human toxicity [10, 19, 22] . There are many reasons for the 20 -30 % failure: i) chemical metabolism, ii) barrier passage, iii) biokinetics, and iv) organ-specific toxicity (neurotoxicity, hepatotoxicity, nephrotoxicity, etc.). Alternative testing strategies, including biokinetic models and endpoints for organ specific toxicity, aim to define alerts and correctors to improve this failure rate in prediction when using exclusively cytotoxicity-based assays. Such strategies would either reveal factors that improve the correlation between in vitro cytotoxic data and acute human toxicity, or define alerts that identify outliers (compounds for which the cytotoxicity in vitro data give a false evaluation of their acute human toxicity).
Neurotoxic events are the consequence of the failure of one or several molecular mechanisms (see [30, 39] ) such as the functioning of ion channels (voltage-or ligand-operated ionotropic receptors, such as GABAA, NMDA, AMPA/kainate, and nicotinic acetylcholine), the transport of amino acidergic and aminergic neurotransmitters, neurotransmitter synthesis and degradation involving enzymes, cell energy control, the regulation of cell and mitochondrial membrane potential, intracellular calcium homeostasis and control of the production and inactivation of reactive oxygen species. The amino acids γ-aminobutyric acid (GABA) and glutamate are, respectively, the most common inhibitory and excitatory neurotransmitters in the CNS. Once released into the synapse they act on ionotropic receptors of GABA (GABAA) and glutamate (NMDA and AMPA/kainate). Whereas excessive potentiation of the GABAA receptor activity results in central depression, inhibition of GABAA receptor activity results in overall excitatory symptoms and convulsions in mammals [27, 28] . Conversely, excessive activation of ionotropic glutamate receptors results in excitatory symptoms and in degeneration of neurons through a process known as excitotoxicity [23, 31] .
In vitro evaluation of these neuronal specific and general endpoints requires wellcharacterized cell culture systems. Primary neuronal cultures of cortical and cerebellar granule cells are enriched in GABAergic and cholinergic neurons [41, 42, 48] , and in glutamatergic neurons [14, 38] in cerebellar granule neurons, respectively (aspartate being an analogue of glutamate that is taken up by the cells through the glutamate transport system). Furthermore, both cultured cortical neurons and cerebellar granule cells express functional ionotropic GABAA and glutamate receptors, which are neural targets for depressant, convulsant and excitotoxic compounds. For a review of the functional characteristics of these in vitro systems see [41] .
In the present work we select a set of compounds (Table 1 in Supplementary Material) based on the European project ACUTETOX (www.acutetox.org). We then test the effect of these compounds on several neuronal functional endpoints and on cell viability in primary cultured neurons. Most of the reference compounds were chosen from the MEIC project [9] and the NICEATM/ECVAM In Vitro Cytotoxicity Validation Study [1] and are pharmaceuticals, pesticides, and industrial chemicals, for which data on their acute human toxicity exist. Both compounds whose acute systemic toxicity was well predicted by general cytotoxicity tests and compounds identified as outliers (i.e., their toxicity was poorly predicted) were included in the list. In addition, some of the reference compounds were selected as positive control compounds for specific target endpoints in the nervous system, kidney and liver. The ACuteTox project aims to improve predictability by combining a handful of simple and robust tests that measure complementary parameters such as absorption, distribution and metabolism, as well as organ specificity. The objective of these research activities is to increase knowledge of the mechanisms by which these compounds cause toxicity and to identify corrector/alert assays in order to improve the in vivo / in vitro correlation. The compounds selected have been tested by different research groups using relevant in vitro assays and in silico approaches including basal cytotoxicity, barrier passage, metabolism, hepatotoxicity, renal toxicity and neurotoxicity. Here we present results concerning GABAergic and glutamatergic neurotransmission (as the main depressant and excitatory neural systems) and cell membrane potential (which determines neural electrical excitability) in primary cultures of cortical neurons and of cerebellar granule cells.
Methods

Materials
Pregnant NMRI mice (16 th day of gestation) and 7-day-old NMRI mice were obtained from Charles River, Iffa Credo (St. Germain-sur-l'Arbreste, France). Plastic multi-well culture plates were purchased from Nunclon TM Nunc TM (Roskilde, Germany). Foetal calf serum was obtained from Gibco (Invitrogen, Barcelona, Spain) and Dulbecco's modified minimum essential medium (DMEM) from Biochrom (Berlin, Germany). 36 The chemicals were dissolved and diluted in HEPES-buffered saline solution or in DMSO. When dissolved in DMSO, a 200 x concentration was prepared, thus the concentration of DMSO in the testing solution was 0.5%. Controls contained the same amount of DMSO, when so required.
Neuronal Cultures
Primary cultures of cortical neurons were obtained from neocortices from 16-day-old mice foetuses, using 10 -12 foetuses from one pregnant mouse for each culture preparation.
Pregnant animals were anesthetized with isofluorane (FORANE®, Abbott Laboratories SA, Madrid, Spain) and killed by cervical dislocation. Primary cultures of cerebellar granule cells were obtained from 7-day-old pups, using a litter of 10 pups per culture. Pups were killed by decapitation.
Primary cultures were prepared as previously described [3, 15] . In brief, the neocortices from foetuses or cerebella from pups were minced, with cells then dissociated by mild trypsinization (0.02 -0.025 % w/v) at 37ºC for 10 min followed by trituration in a DNAse solution (0.004% w/v) containing a soybean trypsin inhibitor (0.05% w/v). The cells were re-suspended in modified DMEM solution (31 mM glucose and 0.2 mM glutamine), supplemented with insulin, penicillin and 10% foetal calf serum, containing 5 mM KCl for cortical neurons and 25 mM KCl for cerebellar granule cells. The cell suspension (1.6 x 10 6 cells/ml) was seeded in 24-well plates (0.5 ml/well) and 96-multi-well plates (0.1 ml/well), pre-coated with poly-D-lysine, and incubated for 6-9 days in a humidified 5% CO2 / 95% air atmosphere at 36.8ºC without changing the culture medium. After 24 -48 h in culture, the primary cultures were treated with the mitotic inhibitor (5 µM 5-fluoro-2'-deoxyuridine and 20 µM uridine) to prevent glial proliferation. Cells were fully differentiated after 6 -8 days in vitro and ready to use for the testing assays. Usually, 6 plates of 
Chloride influx
Chloride influx was determined as 36 Cl -uptake in intact cell cultures of cortical neurons grown in 24-well plates [15, 45] . Briefly, the culture medium was replaced by a pre-warmed Earle's balanced salt solution (EBSS: 116 mM NaCl, 1.8 mM CaCl2, 0.8 mM MgSO4, 1 mM NaH2PO4, 15.2 mM NaHCO3 and 5.5 mM glucose, adjusted to pH 7.4) and cell cultures were incubated in a humidified 5% CO2/ 95% air atmosphere at 36.8ºC. After 30 min incubation, the buffer was replaced by new EBSS solution and incubation continued for an additional 15 min. Cells were pre-incubated with test agent solutions prepared in EBSS for 10 min at room temperature. After this, the cells were incubated for 10 sec with 225 μl HEPES-buffer (HBSS: 136 mM NaCl, 5.4 mM KCl, 1.2 mM CaCl2, 1.4 mM MgCl2, 1.0 mM NaH2P04, 10 mM HEPES and 9 mM glucose, adjusted to pH 7.3) containing 36 Cl -(0.4 µCi/ml), 5 µM or 100 µM GABA and different concentrations of the test agents. 100 µM picrotoxinin was used as a positive control of the assay. Plates where picrotoxinin did not inhibit GABA-induced 36 Cl -uptake were discarded. After removing the 36 Cl -solution, each well was immediately rinsed four times with 1.5 ml cold HBSS solution. Cells were lysed by water-induced hyposmotic shock, and radioactivity was determined by liquid scintillation counting in a Wallac 1414 Winspectral TM . for GABA in cortical neurons [44] ) and different concentrations of the test agents. The assay was terminated by rapid washing with ice-cold buffer. The cells were digested with 0.2 M NaOH overnight and incorporated radioactivity was determined by liquid scintillation counting. Specific uptake was determined by subtracting radioactivity measurements carried out in the presence of 5 mM GABA.
Flunitrazepam binding assay
Glutamate Uptake
Glutamate transport was determined as [ 3 H]-D-aspartate uptake, since D-aspartate is a non-metabolized substrate for glutamate transporters, as previously reported [12] . Primary cultures of cerebellar granule cells were washed three times with HBSS solution and incubated with HBSS buffer containing [ 3 H]-D-aspartate (3 nM), 60 µM glutamate (Km for glutamate transport in cerebellar granule cells [47] ) and different concentrations of the test agent for 10 min at 36ºC. Cells were digested in 0.2 M NaOH overnight and incorporated radioactivity was determined by liquid scintillation counting. Specific uptake was determined by subtracting radioactivity measurements carried out in the presence of 1 mM glutamate.
Intracellular calcium in Mg 2+ -free buffer
The increase of intracellular calcium in cultured cortical neurons in Mg 2+ -free buffer was used to determine the activity of chemicals on N-methyl-D-aspartic acid (NMDA) receptors, as previously described [2, 3] . In brief, NMDA receptor function was determined by measuring the 
Cell viability
The LDH assay was used to determine cell membrane leakage. Cultured cortical neurons grown in 96-well plates were rinsed and incubated for 30 min at 36ºC with HEPES buffered saline solution containing different concentrations of the test agents. Control wells contained the vehicle, and Triton X-100 was added to three wells to obtain maximum cytotoxicity. The activity of the released LDH was determined in an enzymatic test by using the Cytotoxicity Detection Kit from Roche, according to the manufacturer's instructions. In brief, after removing the incubation solution, 100 μl of the LDH Reagent Solution was added to each well. The cells were incubated in the dark at room temperature for 30 min, in an orbital shaker. Thereafter, the enzymatic reaction was stopped by adding 50 µl 1M HCl to each well. After removing the bubbles, the absorbance was measured at 492 nm in a spectrophotometer plate reader, using a reference wavelength of 620 nm (iEMS Reader MF; Labsystems, Helsinki, Finland ).
The reduction of MTT to a coloured formazan salt by mitochondrial reducing activity, was measured as previously described [15] . Briefly, cells grown in 96-well plates were rinsed and incubated for 30 min at 36ºC with HEPES buffered saline solution containing different concentrations of the test agents or vehicle. Following the incubation period, the cells were rinsed with HBSS solution and then incubated for 20 min at 37ºC with 100 µL MTT reagent solution (0.25 mg/ml). After removal of the MTT solution, 100 µl of solubilization solution (SDS 5% w/v) was added to each well and the cells were kept overnight at 37ºC in darkness. Absorbance was measured at a wavelength of 560 nm using a spectrophotometer plate reader (iEMS Reader MF; Labsystems).
Data analysis
Results are expressed as mean ± S.E.M of at least 3 independent experiments.
Concentration-response curves were fitted to sigmoid curves using the GraphPad Prism Human blood 50% lethal concentrations (LC50), expressed in moles per litre (M), were adapted from recently published data [37] . The data for the chemicals used in this study were taken from Acutoxbase which is a part of the integrated ACuteTox project (2005) (2006) (2007) (2008) (2009) ) under the EU 6 th Framework Programme [7] . At present, Acutoxbase includes 97 reference chemicals of
Results
The first set of reference compounds were evaluated against the different neuronal assays used in this work. After completion of the study, the GABAA receptor assay was selected (see below)
for the testing of the additional compounds included in the second set of reference compounds.
In vitro assays of GABA neurotransmission
We determined the effects on the GABAA receptor of the whole set of reference compounds. 23 out of the 58 compounds tested inhibited GABAA receptor activity, as determined by measuring the 36 Cl -uptake induced by 100 µM GABA. Table 1 shows the IC20, IC50, IC80 and Imax values. Diazepam, phenobarbital, mercuric chloride, chloral hydrate and isopropyl alcohol increased GABA-induced Cl -influx (Table 1 ). All together, twenty-eight out of the fifty-eight compounds tested positive against the GABAA receptor. The assay was developed as a nonrobotic, medium-throughput, screening assay using 24-well plates, performing a whole test agent concentration-response curve in each plate. Throughout this work, the intra-assay variability (repeatability) of 36 Cl -influx for the control wells in each individual plate accounted for 12 ± 0.6 % (3 replicates in each plate; n = 105 plates). The intra-assay variability of 36 Cl -influx for the control wells corresponding to different plates from 25 culture preparations (3 -6 plates for each preparation) accounted for 17 ± 3 %.
We have previously shown that [ 3 H]-flunitrazepam binding in primary cultured neurons is increased by GABA, neurosteroids and depressant compounds that act on the GABAA receptor, and that this increase is reduced in the presence of GABAA receptor antagonists [15, 40, 43, 44] .
We wanted to test whether this indirect assay of the GABAA receptor activity, based on the allosteric increase by GABA of the binding of benzodiazepines, could be used as an alternative testing assay for the GABAA receptor function. Figure 1 shows the concentration-response curves for bicuculline ( Figure 1A ) and picrotoxinin ( Figure 1B) 36 Cl -uptake in the presence of 100 µM GABA in primary cultures of cortical neurons. The two assays gave IC50 values that were not statistically significantly different (44 ± 6 µM and 36 ± 7 µM for bicuculline, and 76 ± 21 µM and 37 ± 6 µM for picrotoxinin, against 36 Cl -uptake and [ 3 H]-flunitrazepam assays, respectively; p > 0.1). Reference compounds that were found to inhibit the 36 Cl -influx assay were tested using the [ 3 H]-flunitrazepam binding assay. Figures 2A and 2B show the concentration-response curves for some of the compounds listed in Table 1 . Figure 3 shows the correlation between IC50 values for [ 3 H]-flunitrazepam binding and 36 Cl -uptake in the presence of 100 µM GABA in primary cultures of cortical neurons. A high correlation (r 2 = 0.9108; p < 0.0001) and a slope value of 1.03 was found.
We also tested whether reference compounds could inhibit [ 3 H]-GABA uptake, since a defect in the GABA transport system would result in an excess of extracellular GABA and lead to increased activity of neuronal GABA receptors, which would produce depression. Ten out of the twenty-three chemicals tested from the 1 st set of reference compounds inhibited [ 3 H]-GABA uptake in primary cultured cortical neurons. Table 2 shows the IC20, IC50 and IC80 values for these compounds.
In vitro assays of glutamate neurotransmission and of cell membrane depolarization
We have previously reported that primary cultures of cerebellar granule cells express NMDA-and AMPA/kainate-glutamate receptors and the neuronal transporter EAAT3 [2, 3, 12, 41] .
Activation of ionotropic glutamate receptors results in a Ca 2+ influx through the NMDA receptor when the membrane is depolarized or in a Na + influx through AMPA and kainate receptors leading to cell membrane depolarization.
We tested the 1 st set of reference chemicals against Five out of the twenty-three chemicals tested from the 1 st set of reference compounds inhibited [ 3 H]-aspartate uptake in cultured cerebellar granule cells. We tested the effect of the 1 st set of reference compounds against cell membrane potential in primary cultures of cortical neurons. Nine out of the twenty-three chemicals tested modified basal FMP fluorescence. Figure 4 shows the concentration-response curves for the compounds that modified basal cell membrane potential. We also tested whether this assay could be used to identify compounds that inactivate neuronal Na + channels, as this mechanism underlies the effects of some animal toxins, anaesthetics and anticonvulsant drugs. Veratridine specifically causes persistent activation of Na + channels and increases FMP fluorescence in cultured neurons [41] . The increase in fluorescence induced by 20 µM veratridine was inhibited by carbamazepine (IC50 = 120 ± 16 µM, n = 3) in agreement with its mechanism of action inactivating Na + channels [26] . Carbamazepine did not modify FMP fluorescence, indicating that it does not modify cell membrane potential by itself.
Cell viability
The first set of reference compounds were analyzed for their effects on cell viability after 30 min exposure. This exposure time was slightly longer than that used in the neurofunctional assays (5 -20 minutes). Only sodium lauryl sulphate (SDS) released intracellular LDH (IC50 = 2.2E-4 ± 0.3E-4 M) indicating cell membrane leakage. SDS also reduced mitochondrial activity at similar concentrations. Lower concentrations of SDS (≤ 1E-4 M) did not release LDH or reduce mitochondrial activity. Pentachlorophenol reduced mitochondrial activity (IC50 = 6.9E-5 ± 0.7E-5 M) without releasing intracellular LDH, suggesting that mitochondria failure preceded cell membrane damage. Mercuric chloride also reduced mitochondrial activity (IC50 = 4.7E-6 ± 0.3E-6 M), however, the effect of mercuric chloride on cell membrane integrity could not be determined due to the interference of Hg 2+ with the LDH assay. The 2 nd set of reference compounds did not produce cell cytotoxicity at the concentrations used in the functional GABAA receptor, as visualized by phase-contrast optical microscopy (data not shown). Figure 5 shows a mosaic colour diagram that summarizes human toxicity data [37] and in vitro neural data for the compounds analyzed. Basal cytotoxicity data on the non-neural cell line 3T3 [37] is also included, to compare in vitro neuronal endpoints and basal cytotoxicity. This comparison allowed us to establish neurotoxic alerts for the compounds that were more active at the neuronal than at the basal cytotoxicity endpoints in the 3T3 cell line. The GABAA receptor and the cell membrane potential assays were the tests that identified most compounds. For the most toxic compounds analyzed (human blood lethal concentration -LC50-values < 1E-5 M; black and blue colours in the diagram), the GABAA receptor and the FMP assays produced a neurotoxic alert with respect to the cytotoxicity 3T3 assay for methadone, lindane, malathion, parathion, strychnine and digoxin. Atropine and nicotine were recognized by the neurotoxic assays at concentrations similar to those producing cytotoxicity in the 3T3 cell line, whereas colchicine and verapamil did not produce a neurotoxic alert. For the compounds causing medium levels of toxicity (human blood LC50 values in the range 1E-5 M to 1E-3 M; pink and yellow colours), the neuronal GABAA receptor and the FMP assays gave a neurotoxic alert for diazepam, rifampicine, caffeine, phenobarbital and pentachlorophenol, while warfarin, carbamazepine and mercuric chloride were recognized by the neural assays at concentrations similar to those producing cytotoxicity in the 3T3 cell line. Mercuric chloride produced a neurotoxic alert in the GABA uptake and glutamate uptake assays. Compounds whose toxic blood concentrations were < 1E-3 M (green and white colours) did not modify any of the neural endpoints studied. Isopropyl alcohol was an exception, since it was detected in the GABAA receptor assay as a neuroactive compound.
Predictive value of the in vitro neurofunctional assays
4.-Discussion
In this work we provide evidence that in vitro cell-based functional neuronal tests can be used to identify chemical compounds that interfere with excitatory and inhibitory neurotransmission.
Fifteen out of the twenty-one compounds in the first set of chemicals tested were identified as toxic by at least one of the five neuronal endpoints assayed in primary cultured neurons.
Acetaminophen, acetylsalicylic acid, sodium valproate, glufosinate ammonium, ethanol and cycloheximide did not modify the assayed endpoints up to 1 mM. However, these compounds are known to be of low acute toxicity in humans and rats. The GABAA receptor assay identified the highest number of agents tested from the 1 st set of reference compounds, among them atropine, lindane, malathion, pentachlorophenol, carbamazepine, and methadone, which result in seizures after severe human intoxication (Clemedson and Kolman, private communication within the AcuteTox consortium, forthcoming). Furthermore, diazepam, phenobarbital, chloral hydrate and isopropyl alcohol were recognized as GABAA receptor potentiators; they are CNS depressants at therapeutic and toxic doses. Because of the high capacity of the GABAA receptor to recognize neurotoxic compounds (even when the receptor was not their primary neuronal target) we extended this assay to the second set of 36 reference compounds. The pesticide parathion, which shares with malathion a phosphothiol group, was also identified as toxic by the GABAA receptor. Strychnine, a competitive antagonist of the glycine receptor-operated Cl -channel, also inhibited the GABAA receptor-operated Cl -channel; however, it was less potent on the GABAA than the glycine receptor [45] . The oral contraceptive hormone 17α-ethynylestradiol was also identified as toxic by the GABAA receptor assay. It has been reported that ß-estradiol and its derivative 17α-ethynylestradiol reduce the effect of GABA on human recombinant rho-1-subunit GABA receptors [24] , in agreement with a recent report suggesting that the proconvulsant-like effects of testosterone could be mediated by increased synthesis of 17 β-estradiol [33] . According to our results, 17α-ethynylestradiol might produce a toxic response in the form of seizures, however at blood concentrations much higher than those required for its therapeutic use (95-160 ng/L) (Clemedson and Kolman, private communication within the AcuteTox consortium, forthcoming). A literature search confirms the GABAA receptor effects for 61% of the compounds shown to be active in the present work, while there were no data for 36% of the compounds and one compound (epinephrine) was reported not to act on the GABAA receptor, although at concentrations far lower than those used in the present work (see Table 1 for the effects of compounds on the GABAA receptor and Table 1 in Supplementary Material for related references). With respect to the 27 compounds tested that did not show activity on the GABAA receptor in our assay, there are reports for 4 of them confirming our results and no data for 20 compounds. Three compounds (valproate, caffeine and ethanol) have been demonstrated to be active, however, at higher concentrations than those used in this study. Only one compound, amitryptyline has been reported to inhibit GABAA receptor function but was not recognized in our assay.
The GABAA receptor has binding and recognition sites for a multiplicity of drugs and chemicals, including benzodiazepines, barbiturates, neurosteroids, anaesthetics, avermectin, polychlorocycloalkane pesticides, Zn 2+ and lanthanides [25, 36, 49] . It is structurally composed of 5 subunits (two α, two β and one γ), the interface between the α and β subunits and between the α and γ subunits allocate the binding sites for GABA and benzodiazepines, respectively. Each subunit has extracellular C-and N-terminus domains and four transmembrane domains (TM1-4).
While TM2 faces the lumen of the Cl -channel and TM4 is anchored in the lipid membrane, the transmembrane segments TM1 and TM3 interact with the neighbouring subunit. It has been proposed that such an arrangement would allow conformational flexibility and would provide the receptor with space or cavities for putative binding sites. This model allows for new drug binding sites to be proposed [20] . Therefore, the GABAA receptor has a high capacity to be targeted by a wide range of chemicals. In fact, it has been reported that several nicotinic antagonists also inhibited GABAA receptor function [35] .
In this work, the GABAA receptor activity was determined by measuring the uptake of 36 Cl -induced by GABA in primary neuronal cultures. As we previously reported, this assay recognizes both chemicals that potentiate and those that inhibit the GABAA receptor [15, 32, 44, 45] . However, the high energy of the radionuclide 36 Cl (710 keV) requires the use of acrylamide screens and tube-holders to protect the analyst against the high beta-radiation emitted by 36 Cl. Furthermore, 36 Cl has a long disintegration half-life (3 x 10 5 years). All of this poses technical and environmental drawbacks for the acceptance of this test in high-throughput screening frameworks. Therefore, developing an assay for the GABAA receptor using 3 H (19 keV; 12-year half-life) instead of 36 Cl will result in a clear improvement. It has been demonstrated that binding to a site at the GABAA receptor exerts allosteric modulation on the other independent recognition sites [11, 15, 43, 44] . In this work we provide evidence that the binding of suggests that both assays can be used indistinctly to test for inhibition or blocking of GABAA receptor activity. This binding assay, although still using tritium radioactivity, is much more friendly than the radiometric 36 Cl -influx assay and much more prone to be automated.
Standardization of this method and further validation could give rise to a high-throughput assay for the activity of chemicals on the GABAA receptor. Electrophysiology is the technique that provides most information on GABAA receptor function; however, this methodology requires very specific equipment, high researcher expertise and is not amenable to high throughput. The development of multielectrode chambers where primary neuronal cultures can be grown is also creating expectations for their use in functional neurotoxicity screening [4, 46] .
Chemical compounds may produce hyperexcitability by directly activating ionotropic glutamate receptors or by increasing extracellular glutamate, which in turn will activate these receptors, resulting in degeneration of neurons through a process known as excitotoxicity [23, 31] . [5, 13, 17, 34] ) than of GABA transport (170-1400 µM; this work).
However, since GABA and monoaminergic transporters, but not glutamate transporters, belong to the same slc6 protein family [6] , the inhibition of the GABA transport in cultured cortical neurons could be used as a specific alert for neurotoxicity. Furthermore, compounds like tiagabine that inhibit GABA uptake might have anticonvulsant properties [16] .
In this work we used the cell membrane potential fluorescent probe FMP as a nonspecific assay to identify compounds that modify neuronal excitability, whatever the mechanism.
We recently reported that the FMP fluorescence assay for cell membrane potential responds to different depolarizing stimuli mediated by voltage-and receptor-operated ion channels in cultured neurons. KCl, veratridine, and glutamate and kainate increase FMP fluorescence at concentrations compatible with activation of Na + and AMPA/kainate receptors, respectively [41] .
Nine out of the twenty-three chemicals in the 1 st set of reference compounds modified FMP fluorescence. The assay was able to recognize compounds acting at different neuronal endpoints, such as nicotine at the nACh receptor and digoxin which inhibits Na + /K + /ATPase. The increase in FMP fluorescence by the microtubule disruptor agent colchicine is in agreement with the effects observed in cardiac myocytes, where colchicine increases sodium but not calcium currents [29] . The decrease of FMP fluorescence caused by caffeine could be indicative of a hyperpolarizing shift of membrane potential after ryanodine receptor activation, as demonstrated in mammalian neurons [18] . Neither lindane nor malathion, which inhibited GABAA receptor activity, modified membrane potential. The effect of SDS on FMP fluorescence could be attributed to membrane disruption since EC50 values for FMP fluorescence and cytotoxicity in cortical neurons were similar (1 -3 E-4 M). Furthermore, the compounds that showed sensitivity to glutamate endpoints (mercuric chloride, pentachlorophenol and digoxin) were also recognized by the cell membrane potential assay. The advantages of this method are that it can recognize compounds interfering with different neuronal targets that modify neuronal excitability and that the assay can be easily brought to high-throughput standards. [37] shows that neurotoxic alerts have been established for compounds known to be neuroactive, causing hyperexcitability or depression of the nervous system (lindane, malathion, parathion, strychnine, methadone, digoxin, diazepam, phenobarbital and caffeine). Except for phenobarbital and caffeine, these compounds were outliers when their toxicity was predicted from in vitro basal cytotoxicity assays [37] . We can conclude that a better prediction of acute human toxicity has been obtained by using in vitro neuronal functional assays. Nicotine, also an outlier in the basal cytotoxicity assay prediction, was recognized by the neuronal FMP assay, however, its toxicity was not better predicted. The FMP assay should be refined to detect compounds acting on the nicotinic acetylcholine receptor. In this work, the GABAA receptor, the GABA uptake and the cell membrane potential assays were those that recognized the highest number of chemicals at low concentrations. Furthermore, we have previously reported that the organophosphate pesticides dichlorvos and malathion inhibited AChE activity in primary cultures of cortical neurons [4] , a mechanism that results in central and peripheral nervous system excitability.
In this work we used primary cultures of cortical and of cerebellar granule neurons because they are widely used and they are produced in high yields. They are also well characterized in terms of pre-synaptic and post-synaptic amino acid and acetylcholine neurotransmission; the major neurotransmitter systems involved in acute neurotoxicity. However, it can be argued that these cultures may not recognize chemicals that exhibit regional and cellular specificity such as, for example, dopaminergic toxins. The use of primary cultures obtained from the whole cerebral tissue could overcome this problem once they are fully characterized.
Neurogenesis occurs at different embryonic ages for the different cell types in the brain, thus determining the viability and differentiation of the cells in culture.
We conclude that in vitro evaluation of neural endpoints in primary neuronal cultures may identify compounds that produce acute neurotoxicity in humans, provided that in vitro models expressing neuronal targets relevant for acute neural dysfunctions are used. We provide evidence that test methods based on the measurement of the activity of GABAA receptors, GABA transport, AChE and on the measurement of the cell membrane potential are potent candidates to be included in an in vitro testing strategy for neurotoxicity. Further studies and validation of these methods are needed to progress in the development and implementation of medium-to highthroughput alternative methods for the assessment of human neurotoxicity. 
